Inventor · disambiguated record
Toshio Miyata
Also filed as: MIYATA TOSHIO
20 granted patents·17 pending applications·89 citations·filing 1986–2021
93Inventor score
Files withMIYATA TOSHIO7UNIV TOKAI EDUCATIONAL SYSTEM7RENASCIENCE CO LTD6UNIV NORTHWESTERN3MITSUI CHEMICALS INC2
Top patents by PatentIndex Score
37 records- 0193US7297689B2Method for preparing peritoneal dialysateMIYATA TOSHIO·Filed 2005·Granted Nov 20, 2007·31 cites·32 claims
- 0282US7745613B2Method for preparing peritoneal dialysateUNIV TOKAI EDUCATIONAL SYSTEM·Filed 2006·Granted Jun 29, 2010·4 cites·10 claims
- 0368US6919326B1Carbonyl-stress improving agent and peritoneal dialysateKUROKAWA KIYOSHI·Filed 1999·Granted Jul 19, 2005·22 cites·9 claims
- 0467US7169407B1Carbonyl stress-decreasing agentUNIV TOKAI EDUCATIONAL SYSTEM·Filed 2000·Granted Jan 30, 2007·3 cites·16 claims
- 0565US7029906B2Carbonyl stress-ameliorating agentsUNIV TOKAI EDUCATIONAL SYSTEM·Filed 2000·Granted Apr 18, 2006·2 cites·7 claims
- 0664US7026126B1Method for detecting megsin protein and use thereofFUSO PHARMACEUTICAL IND·Filed 2000·Granted Apr 11, 2006·5 cites·10 claims
- 0764US6790617B1Megsin promoterTOSHIO MIYATA·Filed 2000·Granted Sep 14, 2004·1 cites·5 claims
- 0862US11564924B2Pharmaceutical composition formed by combining pyridoxamine compound and thiamine compoundRENASCIENCE CO LTD·Filed 2020·Granted Jan 31, 2023·0 cites·6 claims
- 0962US7417052B2Phenylene derivative having tetrazole ring or thiazolidinedione ringSANKYO CO·Filed 2004·Granted Aug 26, 2008·2 cites·13 claims
- 1060US7645882B2Inhibitor of protein modification products formationMIYATA TOSHIO·Filed 2004·Granted Jan 12, 2010·2 cites·2 claims
- 1160US2004137495A1Meg-4 proteinUNIV TOKAI EDUCATIONAL SYSTEM·Filed 2004·Application pending·0 cites
- 1255US7368251B2MEGSIN proteinUNIV TOKAI EDUCATIONAL SYSTEM·Filed 2004·Granted May 6, 2008·0 cites·1 claims
- 1355US2023355605A1Drug for enhancing fibrinolytic system, and use thereforRENASCIENCE INC·Filed 2021·Application pending·0 cites
- 1452US2022340665A1Inhibitor against expression of immune checkpoint moleculeRENASCIENCE INC·Filed 2020·Application pending·0 cites
- 1551US2006068437A1Meg-3 proteinMIYATA TOSHIO·Filed 2005·Application pending·0 cites
- 1651US2017258791A1Pharmaceutical composition formed by combining pyridoxamine compound and thiamine compoundPROJECT PM CO LTD·Filed 2015·Application pending·0 cites
- 1751US2008263683A1Megsin/Rage/Inos-Overexpressing Renal Disease Model Animals and Methods for Evaluating Compounds Using the Model AnimalsMIYATA TOSHIO·Filed 2004·Application pending·0 cites
- 1850US8809329B2Detection and treatment of schizophreniaITOKAWA MASANARI·Filed 2008·Granted Aug 19, 2014·0 cites·12 claims
- 1949US2020046811A1Methods and compositions for modulating fgf23 levelsUNIV NORTHWESTERN·Filed 2019·Application pending·0 cites
- 2047US2016144001A1Methods and compositions for modulating fgf23 levelsUNIV NORTHWESTERN·Filed 2015·Application pending·0 cites
- 2147US2022143185A1Orally active small molecule inhibitor of pai-1UNIV NORTHWESTERN·Filed 2020·Application pending·0 cites
- 2245US11253519B2Composition used to improve symptoms of autism spectrum disorder, and method using same for improving symptoms of autism spectrum disorderRENASCIENCE CO LTD·Filed 2017·Granted Feb 22, 2022·0 cites·12 claims
- 2345US2014335517A1Detection and treatment of schizophreniaRENASCIENCE CO LTD·Filed 2014·Application pending·0 cites
- 2444US6680370B1Meg-4 proteinMIYATA TOSHIO·Filed 2000·Granted Jan 20, 2004·5 cites·2 claims
- 2544US2009030047A1Peritoneum protecting agentUNIV TOKAI EDUCATIONAL SYSTEM·Filed 2006·Application pending·0 cites
- 2643US10092537B2Use for PAI-1 inhibitorRENASCIENCE CO LTD·Filed 2014·Granted Oct 9, 2018·0 cites·5 claims
- 2743US8415479B2Inhibitor of plasminogen activator inhibitor-1MIYATA TOSHIO·Filed 2009·Granted Apr 9, 2013·0 cites·17 claims
- 2843US2007161691A1Modified-protein formation inhibitorUNIV TOKAI·Filed 2004·Application pending·0 cites
- 2942US2014296256A1Plasminogen activator inhibitor-1 inhibitorRENASCIENCE CO LTD·Filed 2014·Application pending·0 cites
- 3042US2020123581A1Recombinant microorganism, method of producing pyridoxamine or salt thereof using recombinant microorganism, and method of producing pyridoxal or salt thereof using recombinant microorganismMITSUI CHEMICALS INC·Filed 2018·Application pending·0 cites
- 3142US2020149079A1Recombinant microorganism and method of producing pyridoxamine or salt thereof using recombinant microorganismMITSUI CHEMICALS INC·Filed 2018·Application pending·0 cites
- 3238US7951806B2Plasminogen activator inhibitor-1 inhibitorRENASCIENCE CO LTD·Filed 2008·Granted May 31, 2011·0 cites·8 claims
- 3337US2011021579A1Peritoneum protecting agentUNIV TOKAI EDUCATIONAL SYSTEM·Filed 2010·Application pending·0 cites
- 3436US8785473B2Plasminogen activator inhibitor-1 inhibitorMIYATA TOSHIO·Filed 2010·Granted Jul 22, 2014·0 cites·14 claims
- 3536US4702833AFilter apparatusMITAKA KOGYOSHO KK·Filed 1986·Granted Oct 27, 1987·9 cites·5 claims
- 3633US5773720AImpact sensor and manufacturing method thereforOKI ELECTRIC IND CO LTD·Filed 1997·Granted Jun 30, 1998·3 cites·19 claims
- 3729US2013338574A1Oral medicinal composition for patients undergoing peritoneal dialysis and method for using sameKAKUTA TAKATOSHI·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Toshio Miyata files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →